Identifying potential repurposable medications for Parkinson’s disease

Researchers investigated the potential benefits of 23 existing medications for Parkinson's disease (PD) using a method called Mendelian randomization, which uses genetic data to explore causal relationships. Their findings suggest that certain medications, like thyroid preparations and calcium channel blockers, might reduce the risk of PD, while salicylic acid and its derivatives could slow the progression of motor symptoms. However, the relationships are weak, and further studies are needed to confirm these results. This research could guide future drug development and the repurposing of existing drugs for treating PD, offering a potentially faster route to discovering effective treatments.